Search results
Results from the WOW.Com Content Network
Web page provides quick links to everything from acronyms to wholesale distributor and third-party logistics providers reporting. Additional topics include: approved REMS, drug shortages, and...
Search our databases: Drugs@FDA. Find information about most FDA-approved prescription, generic, and over-the-counter drug products. Drug Shortages. Find information about drug shortages...
The table below is a running list of CDER’s novel drugs approvals for 2024. Export Excel. Showing 1 to 23 of 23 entries. *The listed “FDA-approved use” on this website is for...
Drugs approved by the FDA for specific types of cancer are listed on this page. The drug names link to NCI's information summaries about these drugs. The pages are updated when new cancer drugs are approved. See Drugs Approved for Childhood Cancers for a list specific to children. Find drugs approved by the FDA for specific types of cancer.
Drugs@FDA contains information about the following FDA-approved products for human use: Prescription brand-name drug products, generic drug products, and many therapeutic biological products....
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals.
Over the course of 2022, the FDA approved 37 novel (new) drugs. Many are firsts in their class — meaning they work differently than other drugs on the market. And many others help treat rare (orphan) diseases where options have been more limited.
Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread. Learn more about targeted therapy drugs that have been approved by the FDA to treat specific types of cancer.
This list highlights notable medications and vaccines that have been FDA approved so far in 2024. They represent major advancements compared to other available treatment options. We also describe the top 2023 drug and vaccine approvals.
Seven biosimilar medications were FDA approved in 2022. Alymsys (bevacizumab-maly), Fylnetra (pegfilgrastim-pbbk), and Idacio (adalimumab-aacf) are three examples. The FDA also approved two interchangeable biosimilars in 2022: Cimerli (ranibizumab-eqrn) and Rezvoglar (insulin glargine-aglr).